Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Esperion Therapeutics Inc (NASDAQ:ESPR)

25.00
Delayed Data
As of Feb 17
 +1.81 / +7.81%
Today’s Change
9.40
Today|||52-Week Range
25.93
+99.68%
Year-to-Date
No recent news for Esperion Therapeutics Inc.

Today’s Trading

Previous close23.19
Today’s open23.24
Day’s range23.12 - 25.93
Volume1,817,546
Average volume (3 months)423,816
Market cap$563.9M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-1.80%
Earnings growth (this year)-48.07%
Earnings growth (next 5 years)-5.76%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
VSARVersartis Inc+0.65+4.14%
ENTAEnanta Pharmaceutica...+0.15+0.52%
HSKAHeska Corp+0.70+0.85%
ITCIIntra-Cellular Thera...-0.03-0.23%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$0.00
Annual profit (last year)-$49.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tim M. Mayleben
COO, Executive VP-Research &
Development
Narendra D. Lalwani
Corporate headquarters
Ann Arbor, Michigan

Forecasts


Search for Jobs